Baratella Elisa, Ercolani Eleonora, Segalotti Antonio, Troian Marina, Lovadina Stefano, Giudici Fabiola, Minelli Pierluca, Ruaro Barbara, Salton Francesco, Cova Maria Assunta
Radiology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, 34149 Trieste, Italy.
Thoracic Surgery Unit, Cardiothoracic and Vascular Department, University Hospital of Cattinara, 34149 Trieste, Italy.
J Clin Med. 2025 Feb 25;14(5):1547. doi: 10.3390/jcm14051547.
: Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer linked to asbestos exposure and with poor overall survival. In recent years, CT volumetric analysis has gained increasing interest as a more accurate method for assessing tumor burden. This study aims to evaluate the prognostic value of chest CT volumetric analysis in MPM, comparing tumor volume with tumor thickness measurements and survival outcomes. : This is a retrospective, observational analysis of all patients undergoing diagnostic thoracoscopy between 2014 and 2021 at the University Hospital of Cattinara (Trieste, Italy). Inclusion criteria were as follows: age ≥ 18 years, histological diagnosis of MPM, and the availability of at least one contrast-enhanced chest CT scan at the time of diagnosis. For each patient, the tumor thickness was measured on the axial plane at three levels (upper, middle, and lower hemithorax). Tumor and effusion volumes were calculated with the RayStation software version 11.7.174 (HealthMyne, Madison, WI, USA). : A total of 81 patients were eligible for analysis. Maximum and mean tumor thickness were strongly associated with survival, with higher thicknesses correlating with an increased risk of death (adjusted hazard ratio per doubling (aHR) of 1.97 (95%CI: 1.40-2.77) and of 2.23 (95%CI: 1.56-3.20), < 0.001)), respectively, while the effect of the tumor volume on survival was nevertheless significant but less impactful (aHR = 1.26 (1.10-1.45, < 0.001)). The presence and volume of effusion did not correlate with survival ( = 0.48 and = 0.64, respectively). : This study supports the role of quantitative parameters for staging MPM, particularly given the frequent discrepancies between clinical and pathological staging when relying solely on qualitative measures.
恶性胸膜间皮瘤(MPM)是一种罕见的侵袭性癌症,与石棉暴露有关,总体生存率较低。近年来,CT容积分析作为一种更准确的评估肿瘤负荷的方法,越来越受到关注。本研究旨在评估胸部CT容积分析在MPM中的预后价值,比较肿瘤体积与肿瘤厚度测量值及生存结果。
这是一项对2014年至2021年期间在卡蒂纳拉大学医院(意大利的里雅斯特)接受诊断性胸腔镜检查的所有患者进行的回顾性观察分析。纳入标准如下:年龄≥18岁,MPM的组织学诊断,以及诊断时至少有一次增强胸部CT扫描。对于每位患者,在三个层面(上、中、下胸部)的轴位平面上测量肿瘤厚度。使用RayStation软件版本11.7.174(美国威斯康星州麦迪逊市的HealthMyne公司)计算肿瘤和胸腔积液的体积。
共有81例患者符合分析条件。最大和平均肿瘤厚度与生存密切相关,厚度越大,死亡风险越高(每增加一倍的调整后风险比(aHR)分别为1.97(95%CI:1.40 - 2.77)和2.23(95%CI:1.56 - 3.20),P < 0.001),而肿瘤体积对生存的影响虽显著但影响较小(aHR = 1.26(1.10 - 1.45,P < 0.001))。胸腔积液的存在和体积与生存无关(P分别为0.48和0.64)。
本研究支持定量参数在MPM分期中的作用,特别是考虑到仅依靠定性测量时临床分期和病理分期之间经常存在差异。